At Reason, Ronald Bailey writes:
In the Sunday New York Times, bioethicist Ezekiel Emanuel describes how the federal government has created a cancer drug shortage. As he notes:
Right now cancer care is being rationed in the United States… Of the 34 generic cancer drugs on the market, as of this month, 14 were in short supply. They include drugs that are the mainstay of treatment regimens used to cure leukemia, lymphoma and testicular cancer.
Why? Because of what are essentially government prices controls on generic cancer drugs.
Read the whole post: Government Price Controls Produce Cancer Drug Shortage – Who Would Have Guessed?.
Via Anthony Gregory, Independent Institute: The Destructive Evil of Price Controls.
